Table 3.
Patients characteristic | Src expreossion | P-Src expression | Age | Gender | Metastasis | Clinical stage | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
High | Low | High | Low | ≤50 | >50 | Male | Female | Yes | No | I B | II A | II B | III | |
Src expreossion | ||||||||||||||
High | 72 | 1 | 42 | 31 | 42 | 32 | 51 | 22 | 2 | 3 | 40 | 28 | ||
Low | 3 | 40 | 25 | 18 | 30 | 13 | 22 | 21 | 3 | 14 | 24 | 2 | ||
P-Src expression | ||||||||||||||
High | 72 | 3 | 44 | 31 | 42 | 33 | 53 | 22 | 2 | 4 | 40 | 29 | ||
Low | 1 | 40 | 23 | 18 | 29 | 12 | 20 | 21 | 3 | 13 | 24 | 1 | ||
Age | ||||||||||||||
≤50 | 42 | 25 | 44 | 23 | 36 | 31 | 44 | 23 | 3 | 7 | 38 | 19 | ||
>50 | 31 | 18 | 31 | 18 | 35 | 14 | 29 | 30 | 2 | 10 | 26 | 11 | ||
Gender | ||||||||||||||
Male | 40 | 30 | 42 | 29 | 36 | 35 | 45 | 26 | 2 | 9 | 37 | 23 | ||
Female | 32 | 13 | 33 | 12 | 31 | 14 | 28 | 17 | 3 | 8 | 27 | 7 | ||
Metastasis | ||||||||||||||
Yes | 51 | 22 | 53 | 20 | 44 | 29 | 45 | 48 | 2 | 7 | 34 | 30 | ||
No | 22 | 21 | 22 | 21 | 23 | 20 | 26 | 17 | 3 | 10 | 30 | 0 | ||
Clinical stage | ||||||||||||||
I B | 2 | 3 | 2 | 3 | 3 | 2 | 2 | 3 | 2 | 3 | ||||
II A | 3 | 14 | 4 | 13 | 7 | 10 | 9 | 8 | 7 | 10 | ||||
II B | 40 | 24 | 40 | 24 | 38 | 26 | 37 | 27 | 24 | 30 | ||||
III | 28 | 2 | 29 | 1 | 19 | 11 | 23 | 7 | 30 | 0 |